Consultation on NCD Action Plan and Global Coordination Mechanism

The International Agency for the Prevention of Blindness (IAPB) is an alliance of civil society organisations, private sector, and professional bodies promoting eye health through advocacy, knowledge and partnerships.
Organisation: IAPB

World Health Organization

The WHO is holding a consultation on progress on NCDs, a mid-point evaluation on the NCD-GAP and evaluation on the Global Coordination Mechanism on the Prevention and Control of Non-communicable Diseases.

The deadline to contribute to the WHO is 21st August. Given the important links between NCDs and eye health, there may be interest from organisations particularly those already engaging on advocacy or programmatic work around NCDs and eye health  to develop a joint response on this to the WHO. If you are interested to be involved or share perspectives please message Zoe Gray on zgray@iapb.org. Alternatively if your organisation is planning to send its own response, please let us know if we can support in any way.

The WHO Global Action Plan for the Prevention and Control of Noncommunicable diseases, 2013-2030 (NCD-GAP) provides a road map and a menu of policy options for all Member States and other stakeholders, to take coordinated and coherent action, at all levels, local to global, to attain the nine voluntary global targets on NCDs, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2025.

The objectives of the Plan are:

  • Objective 1: to raise the priority accorded to the prevention and control of NCDs in global, regional and national agendas and internationally agreed development goals, through strengthened international cooperation and advocacy
  • Objective 2: to strengthen national capacity, leadership, governance, multisectoral action and partnerships to accelerate country response for the prevention and control of NCDs
  • Objective 3to reduce modifiable risk factors for NCDs and underlying social determinants through creation of health-promoting environments
  • Objective 4to strengthen and orient health systems to address the prevention and control of NCDs and the underlying social determinants through people-centred primary health care and universal health coverage
  • Objective 5to promote and support national capacity for high-quality research and development for the prevention and control of NCDs
  • Objective 6to monitor the trends and determinants of NCDs and evaluate progress in their prevention and control

The mandate to conduct a mid-point evaluation of the progress achieved in the implementation of the NCD-GAP derives from resolution WHA66.10, which endorsed the NCD-GAP. The purpose of the mid-point evaluation is to assess the accomplishments of the six objectives of the NCD-GAP, as well as the lessons learned throughout implementation of the NCD-GAP in Member States; by international partners and non-state actors; and at the three levels of WHO. It will document successes, challenges and gaps in the implementation of the NCD-GAP since 2013; provide lessons learned and strategic recommendations to improve the implementation of the NCD-GAP until 2030; and provide inputs for the next WHO global status report on NCDs and other relevant reports.

Furthermore, another evaluation being undertaken as part of the Executive Board-approved WHO evaluation workplan 2020-21 is the Final evaluation of the Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases, which will assess the effectiveness of the GCM/NCD, its added value and its continued relevance to the achievement of the 2025 voluntary global targets, including its possible extension. This evaluation is being conducted independently of the NCD-GAP evaluation but both evaluation teams coordinate as needed throughout the process to ensure the necessary synergies. The findings from both evaluations will be presented to the 148th session of the Executive Board in January 2021.